
In brief: Revelstoke recaps AOM, Vivos to make buy, state legislation makes tracks
DENVER – Revelstoke Capital Partners, a health care-focused private equity firm, has completed a recapitalization of AOM Infusion, a specialty infusion provider of chronic therapy management. AOM Infusion provides patients with intravenous immunoglobulin, …